Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Distinct regulation and impact of type 1 T‐cell immunity against HPV16 L1, E2 and E6 antigens during HPV16‐induced cervical infection and neoplasia

17 Aug 2005

Abstract excerpt

Cervical cancer is the possible outcome of a genital infection with high-risk human papillomavirus type 16 (HPV16) and is preceded by a phase of persistent HPV infection during which the host immune system fails to eliminate the virus. Our previous work showed that failure is reflected by the absence of type 1 T-cell immunity against HPV16 early antigens E2 and E6 in patients with HPV16+ cervical lesions. We now...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cervical Cancer and HPV Research
Share to Genital Health and Disease
Share to Immune Response and Inflammation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16108057
DOI: 10.1002/ijc.21394

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Distinct regulation and impact of type 1 T‐cell immunity against HPV16 L1, E2 and E6 antigens during HPV16‐induced cervical infection and neoplasiaPMID 16108057Read ↗

Early Defensive Mechanisms against Human Papillomavirus InfectionSemantic proximity Read ↗

Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA‐DQ and –DP as a restriction elementSemantic proximity Read ↗

Detection of human papillomavirus type 18 E6 and E7‐specific CD4+ T‐helper 1 immunity in relation to health versus diseaseSemantic proximity Read ↗

The Invisible Enemy – How Human Papillomaviruses Avoid Recognition and Clearance by the Host Immune SystemSemantic proximity Read ↗

The role of inflammation in HPV carcinogenesisSemantic proximity Read ↗

Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.Semantic proximity Read ↗

Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.Semantic proximity Read ↗

Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.Semantic proximity Read ↗

The Immune Response to Papillomavirus During Infection Persistence and RegressionSemantic proximity Read ↗

A Major Role for the Minor Capsid Protein of Human Papillomavirus Type 16 in Immune EscapeSemantic proximity Read ↗

Detection of human papillomavirus (HPV)-specific T cell response in women with low-grade cervical intraepithelial lesion and HPV vaccinated subjects.Semantic proximity Read ↗

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.